Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
Deloitte
Merck
Chubb
Accenture
Covington
Novartis
Cerilliant
Fish and Richardson

Generated: October 18, 2017

DrugPatentWatch Database Preview

King Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for KING PHARMS LLC, and when can generic versions of KING PHARMS LLC drugs launch?

KING PHARMS LLC has twelve approved drugs.

There are two US patents protecting KING PHARMS LLC drugs.

There are fifty-six patent family members on KING PHARMS LLC drugs in thirty-three countries and four supplementary protection certificates in three countries.

Summary for Applicant: King Pharms Llc

International Patents:56
US Patents:2
Tradenames:12
Ingredients:11
NDAs:12
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc
BICILLIN C-R
penicillin g benzathine; penicillin g procaine
INJECTABLE;INJECTION050138-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
King Pharms Llc
TAPAZOLE
methimazole
TABLET;ORAL040320-002Mar 31, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-001May 25, 1983ABRXYesNo► Subscribe► Subscribe► Subscribe
King Pharms Llc
TILADE
nedocromil sodium
AEROSOL, METERED;INHALATION019660-001Dec 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-002Mar 20, 2002DISCNNoNo► Subscribe► SubscribeY ► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
SOLUTION;INHALATION018596-001May 28, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
King Pharms Llc
ALTACE
ramipril
CAPSULE;ORAL019901-002Jan 28, 1991ABRXYesNo► Subscribe► Subscribe ► Subscribe
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-005Dec 18, 2008DISCNNoNo► Subscribe► SubscribeY ► Subscribe
King Pharms Llc
AVINZA
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL021260-003Mar 20, 2002DISCNNoNo► Subscribe► SubscribeY ► Subscribe
King Pharms Llc
BICILLIN L-A
penicillin g benzathine
INJECTABLE;INJECTION050141-001Approved Prior to Jan 1, 1982BCRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for King Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc
ALTACE
ramipril
CAPSULE;ORAL019901-002Jan 28, 1991► Subscribe► Subscribe
King Pharms Llc
TILADE
nedocromil sodium
AEROSOL, METERED;INHALATION019660-001Dec 30, 1992► Subscribe► Subscribe
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-002May 25, 1983► Subscribe► Subscribe
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-001May 25, 1983► Subscribe► Subscribe
King Pharms Llc
SILVADENE
silver sulfadiazine
CREAM;TOPICAL017381-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
King Pharms Llc
ALTACE
ramipril
CAPSULE;ORAL019901-001Jan 28, 1991► Subscribe► Subscribe
King Pharms Llc
ALTACE
ramipril
CAPSULE;ORAL019901-003Jan 28, 1991► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
AEROSOL, METERED;INHALATION018887-001Dec 5, 1985► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
SOLUTION;INHALATION018596-001May 28, 1982► Subscribe► Subscribe
King Pharms Llc
INTAL
cromolyn sodium
AEROSOL, METERED;INHALATION018887-001Dec 5, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for KING PHARMS LLC drugs

Drugname Dosage Strength Tradename Submissiondate
morphine sulfate
Extended-release Capsules45 mg and 75 mg
AVINZA
7/30/2009
morphine sulfate
Extended-release Capsules30 mg, 60 mg, 90 mg and 120 mg
AVINZA
6/4/2007

International Patent Family for King Pharms Llc Drugs

Country Document Number Estimated Expiration
Norway20020978► Subscribe
Denmark1216038► Subscribe
Norway331616► Subscribe
European Patent Office1023051► Subscribe
Slovenia1216038► Subscribe
Israel148127► Subscribe
China1268331► Subscribe
Russian Federation2005141759► Subscribe
Portugal1023051► Subscribe
World Intellectual Property Organization (WIPO)9920255► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for King Pharms Llc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB98/047United Kingdom► SubscribePRODUCT NAME: COMBINATIONS OF RAMIPRIL, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND FELODIPINE, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: SE 13596 19970919; SE 13597 19970919; UK 00017/0402 19980825; UK 00017/0403 19980825
C0001Belgium► SubscribePRODUCT NAME: FELODIPINUM + RAMIPRILUM; NATL. REGISTRATION NO/DATE: 354 IS 373 F 3 19981103; FIRST REGISTRATION: SE 13597 19970919
80030Netherlands► SubscribePRODUCT NAME: FELODIPINE, DESGEWENST IN DE VORM VAN FYSIOLOGISCH AANVAARDBAAR ZOUT, EN (2S, 3AS, 6AS)-1-[(S)-N-[(S)-1-CARBOXY-3-FENYLPROPYL]A LANYL]OCTAHYDROCYCLOPENTA[B]-PYRROOL-2-CARBONZUUR (RAMIPRILAAT) , DESGEWENST IN DE VORM VAN EEN .....ZIE VERDER IN HET DOSSIER; NAT. REGISTRATION NO/ DATE: RVG 22449, RVG 22450 19980618; FIRST REGISTRATION: SE 13596, 13597 19970919
C/GB03/034United Kingdom► SubscribePRODUCT NAME: MOXIFLOXACIN AND PHARMACEUTICALLY USABLE HYDRATES AND ACID ADDITION SALTS THEREOF AND THE ALKALI METAL, ALKALINE EARTH METAL, SILVER AND GUANIDINIUM SALTS OF THE UNDERLYING CARBOXYLIC ACIDS AND THE RACEMATES THEREOF; REGISTERED: DE 45263.00.00 19990621; UK PL 000 10/0291 20030313
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Teva
Dow
Fuji
Cipla
Chubb
Healthtrust
Johnson and Johnson
Deloitte
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot